Advertisement

Pharmaceutical Research

, Volume 11, Issue 8, pp 1186–1189 | Cite as

Chitosan as a Novel Nasal Delivery System for Peptide Drugs

  • Lisbeth Illum
  • Nidal F. Farraj
  • Stanley S. Davis
Article

Abstract

A nasal solution formulation of the cationic material chitosan was shown to greatly enhance the absorption of insulin across the nasal mucosa of rat and sheep. The absorption promoting effect was concentration dependent with the optimal efficacy obtained for concentrations higher than 0.2% and 0.5% in rats and sheep, respectively. The absorption promoting effect was reversible with time in a “pulse-chase” study. Histological examination of the nasal mucosa of rats exposed to a chitosan solution for 60 minutes showed little change.

chitosan nasal delivery insulin sheep 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Y. Sawayanagi, N. Nambu and T. Nagai. Directly compressed tablets containing chitin or chitosan in addition to mannitol. Chem. Pharm. Bull. 30: 4216–4218 (1982).Google Scholar
  2. 2.
    Y. Sawayanagi, N. Nambu and T. Nagai. The use of chitosan for sustained release preparations of water soluble drugs. Chem. Pharm. Bull. 30: 4213–4215 (1982).Google Scholar
  3. 3.
    T. Imai, S. Shiraishi, H. Saito and M. Otagiri. Interaction of indomethacin with low molecular weight chitosan and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosan. Int. J. Pharm. 67: 11–20 (1991).Google Scholar
  4. 4.
    K. Takayama, M. Hirata, Y. Machida, T. Masada, T. Sannan and T. Nagai. Effect of interpolymer complex formation on bioadhesive proterty and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. Chem. Pharm. Bull. 38: 1993–1997 (1990).Google Scholar
  5. 5.
    S. Miyazaki, K. Ishii and T. Nadai. The use of chitin and chitosan as drug carriers. Chem. Pharm. Bull. 29: 3067–3069 (1981).Google Scholar
  6. 6.
    S. Miyazaki, H. Yamaguchi, C. Yokouchi, M. Takada and W-M. Hou. Sustained release and intragastric-floating granules of indomethacin using chitosan in rabbits. Chem. Pharm. Bull. 36: 4033–4038 (1988).Google Scholar
  7. 7.
    K. Arai, T. Kinumaki and T. Fujita. Toxicity of chitosan. Bull. Tokai Reg. Fish. Lab. 43: 89–94 (1968).Google Scholar
  8. 8.
    C-M. Lehr, J. A. Bouwstra, E. H. Schacht and H. E. Junginger. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78: 43–48 (1992).Google Scholar
  9. 9.
    D. T. O'Hagan and L. Illum. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. CRC Crit. Rev. Ther. Drug Carrier Syst. 7: 35–97 (1990)Google Scholar
  10. 10.
    L. Illum, H. Jorgensen, H. Bisgaard, O. Krogsgaard and N. Rossing. Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm. 39: 189–199 (1987).Google Scholar
  11. 11.
    L. Illum, N. F. Farraj, H. Critchley and S. S. Davis. Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 46: 261–265 (1988).Google Scholar
  12. 12.
    L. Illum, N. F. Farraj, S. S. Davis, B. R. Johansen and D. T. O'Hagan. Investigation of the nasal absorption of biosynthetic human growth hormone in sheep—use of a bioadhesive microsphere delivery system. Int. J. Pharm. 63: 207–211 (1990).Google Scholar
  13. 13.
    N. F. Farraj, B. R. Johansen, S. S. Davis and L. Illum. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Control. Rel. 13: 253–261 (1990).Google Scholar
  14. 14.
    L. Illum and S. S. Davis. Intranasal insulin. Clinical Pharmacokinetics. Clin. Pharmacokinet., 23: 30–41 (1992).Google Scholar
  15. 15.
    P. Edman, E. Bjork and L. Ryden. Microspheres as a nasal delivery system for peptide drugs. J. Control. Rel. 21: 165–172 (1992).Google Scholar
  16. 16.
    S. G. Chandler, L. Illum and N. W. Thomas. Nasal absorption in the rat. I. An in situ method for the demonstration of histological effects resulting from the administration of nasal formulations. Int. J. Pharm. 70: 12–27 (1991).Google Scholar
  17. 17.
    S. Hirai, T. Yashida and H. Mima. Mechanism for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9: 173–184 (1981).Google Scholar
  18. 18.
    D. N. Granger, P. R. Kvietys, M. A. Perry and A. E. Taylor. Charge selectivity of rat intestinal capillaries. Influence of polycations. Gastroenterology 91: 1443–1446 (1986).Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Lisbeth Illum
    • 1
  • Nidal F. Farraj
    • 1
  • Stanley S. Davis
    • 1
  1. 1.Albert Einstein CentreDanBioSyst UK LtdNottinghamUK

Personalised recommendations